Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Lippincott, Williams & Wilkins
2016
|
| _version_ | 1826259625029140480 |
|---|---|
| author | Mehlum, MH Liestøl, K Julius, S Kjeldsen, SE Hua, TA Rothwell, PM Mancia, G Parati, G Weber, MA Berge, E |
| author_facet | Mehlum, MH Liestøl, K Julius, S Kjeldsen, SE Hua, TA Rothwell, PM Mancia, G Parati, G Weber, MA Berge, E |
| author_sort | Mehlum, MH |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:52:49Z |
| format | Conference item |
| id | oxford-uuid:10d41028-1cbb-437a-a0cd-8ce2fcfbea7a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:52:49Z |
| publishDate | 2016 |
| publisher | Lippincott, Williams & Wilkins |
| record_format | dspace |
| spelling | oxford-uuid:10d41028-1cbb-437a-a0cd-8ce2fcfbea7a2022-03-26T09:58:38ZSystolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trialConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:10d41028-1cbb-437a-a0cd-8ce2fcfbea7aEnglishSymplectic ElementsLippincott, Williams & Wilkins2016Mehlum, MHLiestøl, KJulius, SKjeldsen, SEHua, TARothwell, PMMancia, GParati, GWeber, MABerge, E |
| spellingShingle | Mehlum, MH Liestøl, K Julius, S Kjeldsen, SE Hua, TA Rothwell, PM Mancia, G Parati, G Weber, MA Berge, E Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title | Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title_full | Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title_fullStr | Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title_full_unstemmed | Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title_short | Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| title_sort | systolic visit to visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial |
| work_keys_str_mv | AT mehlummh systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT liestølk systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT juliuss systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT kjeldsense systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT huata systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT rothwellpm systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT manciag systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT paratig systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT weberma systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial AT bergee systolicvisittovisitbloodpressurevariabilityincreasesriskofmyocardialinfarctionandcongestiveheartfailureinpatientsgivenvalsartanoramlodipineinthevaluetrial |